Jan-Peter Glossmann1, Nicole Skoetz1, Barbara Starbatty1, Martina Bischoff2, Serge Leyvraz3, Henrike Westekemper4, Ludwig M Heindl5,6. 1. Centrum für Integrierte Onkologie (CIO) Köln Bonn, Universitätsklinikum Köln, Köln, Deutschland. 2. Institut für Medizinische Biometrie und Statistik, Universitätsklinikum Freiburg, Freiburg, Deutschland. 3. Medizinische Onkologie und Charité Comprehensive Cancer Center, Universitätsmedizin Berlin, Berlin, Deutschland. 4. Universitätsaugenklinik und Westdeutsches Tumorzentrum Essen, Universitätsklinikum Essen, Essen, Deutschland. 5. Centrum für Integrierte Onkologie (CIO) Köln Bonn, Universitätsklinikum Köln, Köln, Deutschland. ludwig.heindl@uk-koeln.de. 6. Zentrum für Augenheilkunde, Universität zu Köln, Kerpener Straße 62, 50924, Köln, Deutschland. ludwig.heindl@uk-koeln.de.
Abstract
BACKGROUND: In cases of rare cancer entities, such as malignant melanoma of the conjunctiva, there are often no evidence-based national guidelines available. Standard operating procedures (SOP) are an alternative in these cases. OBJECTIVE: The aim of this project was to develop a consensus SOP for diagnosis, treatment, and follow-up care of conjunctival melanomas between the 14 Centers of Excellence in Germany supported by German Cancer Aid. METHODS: The SOP was prepared according to a defined process including timelines, flow of information, and roles. RESULTS AND CONCLUSION: This is the first consensus SOP of the Centers of Excellence in Germany (certified by the German Cancer Aid) regarding diagnosis, treatment, and follow-up for malignant melanomas of the conjunctiva.
BACKGROUND: In cases of rare cancer entities, such as malignant melanoma of the conjunctiva, there are often no evidence-based national guidelines available. Standard operating procedures (SOP) are an alternative in these cases. OBJECTIVE: The aim of this project was to develop a consensus SOP for diagnosis, treatment, and follow-up care of conjunctival melanomas between the 14 Centers of Excellence in Germany supported by German CancerAid. METHODS: The SOP was prepared according to a defined process including timelines, flow of information, and roles. RESULTS AND CONCLUSION: This is the first consensus SOP of the Centers of Excellence in Germany (certified by the German CancerAid) regarding diagnosis, treatment, and follow-up for malignant melanomas of the conjunctiva.
Entities:
Keywords:
Aftercare; Conjunctiva; Neoplasms; Quality of care; Standard of care
Authors: Ludwig M Heindl; Carmen Hofmann-Rummelt; Werner Adler; Jacobus J Bosch; Leonard M Holbach; Gottfried O H Naumann; Friedrich E Kruse; Claus Cursiefen Journal: Ophthalmology Date: 2011-08-11 Impact factor: 12.079
Authors: Carol L Shields; Jeremy S Markowitz; Irina Belinsky; Hal Schwartzstein; Nina S George; Sara E Lally; Arman Mashayekhi; Jerry A Shields Journal: Ophthalmology Date: 2010-08-17 Impact factor: 12.079
Authors: Ludwig M Heindl; Carmen Hofmann-Rummelt; Werner Adler; Jacobus J Bosch; Leonard M Holbach; Gottfried O H Naumann; Friedrich E Kruse; Claus Cursiefen Journal: Invest Ophthalmol Vis Sci Date: 2011-09-09 Impact factor: 4.799